JIN MEDICAL INTERNATIONAL LTD. ORDINARY SHARES

NASDAQ: ZJYL (JIN MEDICAL INTERNATIONAL LTD.)

Last update: 14 hours ago

1.94

-0.15 (-7.22%)

Previous Close 2.09
Open 1.95
Volume 3,059
Avg. Volume (3M) 722,584
Market Cap 144,847,040
Price / Earnings (TTM) 10.21
Price / Sales 0.800
Price / Book 4.91
52 Weeks Range
1.53 (-21%) — 8.48 (337%)
Earnings Date 23 Jan 2026
Profit Margin 15.64%
Operating Margin (TTM) 18.61%
Diluted EPS (TTM) 0.020
Quarterly Revenue Growth (YOY) 35.30%
Quarterly Earnings Growth (YOY) 69.20%
Total Debt/Equity (MRQ) 40.64%
Current Ratio (MRQ) 2.50
Operating Cash Flow (TTM) -1.21 M
Levered Free Cash Flow (TTM) 3.12 M
Return on Assets (TTM) 5.78%
Return on Equity (TTM) 13.02%

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Mixed Mixed
Medical Instruments & Supplies (Global) Mixed Mixed
Stock JIN MEDICAL INTERNATIONAL LTD. - -

AIStockmoo Score

-0.3
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 1.0
Technical Oscillators -0.5
Relative Valuation -5.0
Financial Health 5.0
AI Insight NA
Weighted Average -0.30

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ZJYL 145 M - 10.21 4.91
XRAY 2 B 1.87% - 1.44
ANGO 473 M - - 3.75
EMBC 368 M 4.93% 4.41 -
OSUR 255 M - - 0.870
UTMD 238 M 1.66% 22.82 1.96

Select this tab to load the latest available analysis.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Small Value
% Held by Insiders 75.84%
% Held by Institutions 0.64%

No data within this time range.

No data within this time range.

AI Technical Analysis

Open the Technical tab to generate the latest analysis.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria